RE: Presentation.15 Sep 2022 15:50
Hi Shandy,
I share your concerns.
My feeling now is that it's all 18 months on and I'm hopeful that the bigger boys can see the pathway to profitability and the disruption to the market that can be caused and are now getting interested. The raise up to $150 odd per package is encouraging and will start to boost revenue significantly in H2?
Re Norgine - I thought his statement concerning their top brass embracing a change of strategy is potentially big news that could make quite a difference, as it has been doing stateside. They, like us, can see the benefits of shifting into women's health. Again, H2 could yield some excellent growth, fingers crossed.
All in all, I feel we have a crucial period upcoming which could turn it around into a good position for 2023.
Best of luck to everybody invested here.